Health care stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.1% and the iShares Biotechnology ETF (IBB) down 0.2%.

Cardinal Health (CAH) shares were up more than 3% after the company said it now expects at least $10 in fiscal 2026 non-GAAP earnings per diluted share, up from its prior outlook of $9.65 to $9.85.

Argenx (ARGX) stock was up more than 1% after the company said its supplemental biologics license application for Vyvgart has received the US Food and Drug Administration's acceptance for priority review to treat adults with acetylcholine receptor antibody seronegative generalized myasthenia gravis.

National Vision (EYE) shares were down more than 6% after the company said it continues to expect fiscal 2025 adjusted earnings of $0.63 to $0.71 per diluted share and revenue of between $1.97 billion and $1.99 billion.